Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp clinical trials

Explore recruiting chronic inflammatory demyelinating polyradiculoneuropathy cidp clinical trials.

Recruiting chronic inflammatory demyelinating polyradiculoneuropathy cidp studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Xembify versus Gamunex-C in Participants with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Romania, Czechia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Single-Arm, Multiple-Dose, Pharmacokinetic Comparability Trial Between TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Denmark, Czechia, Sweden, Poland, Italy, Germany +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp trials by city

Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Toronto Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Vancouver Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Montreal Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Calgary Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Edmonton Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Ottawa Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Winnipeg Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Quebec City Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Hamilton Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Kitchener Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in London Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Halifax Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in New York Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Los Angeles Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Chicago Chronic Inflammatory Demyelinating Polyradiculoneuropathy Cidp in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease